Heart Monitoring Device After Acute Myocardium Infarction (Monitor)
Primary Purpose
Acute Myocardial Infarction
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Heart monitor
No heart monitor
Sponsored by
About this trial
This is an interventional prevention trial for Acute Myocardial Infarction focused on measuring Monitoring, Myocardial infarction, Clinical trial
Eligibility Criteria
Inclusion Criteria:
- patients over 18 years
- patients post-acute myocardial infarctium
Exclusion Criteria:
- patients with neurological disease
- patients with congenital heart disease
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Heart Monitor
No Heart Monitor
Arm Description
We used the device (heart monitor) in the patients with myocardial infarction.
No heart monitor device in the patients with myocardial infarction (control).
Outcomes
Primary Outcome Measures
Heart rhythm monitoring
Evaluating the effectiveness of a heart monitoring device in the prevention and detection of events in patients after acute myocardial infarction
Secondary Outcome Measures
Full Information
NCT ID
NCT03494751
First Posted
January 22, 2018
Last Updated
April 4, 2019
Sponsor
Instituto de Cardiologia do Rio Grande do Sul
1. Study Identification
Unique Protocol Identification Number
NCT03494751
Brief Title
Heart Monitoring Device After Acute Myocardium Infarction
Acronym
Monitor
Official Title
Heart Monitoring Device After Acute Myocardium Infarction
Study Type
Interventional
2. Study Status
Record Verification Date
April 2018
Overall Recruitment Status
Unknown status
Study Start Date
May 1, 2019 (Anticipated)
Primary Completion Date
September 1, 2019 (Anticipated)
Study Completion Date
July 1, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Instituto de Cardiologia do Rio Grande do Sul
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Verify the effectiveness of a Heart Monitor in preventing events in patients over 18 years after acute myocardial infarction in a clinical unit. Patients with neurological disease or congenital heart disease we excluded from the study.
Detailed Description
Heart Monitor can detect early intercurrences. Objective: To verify the effectiveness of a Heart Monitoring system in preventing events in patients after acute myocardial infarction. Methodology: This is a randomized clinical trial to be developed in a clinical unit and will include patients over 18 years , post-acute myocardial infarction who were transferred from the ICU emergency or hemodynamic to clinical unit. Patients with neurological disease or congenital heart disease will be excluded from the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction
Keywords
Monitoring, Myocardial infarction, Clinical trial
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
358 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Heart Monitor
Arm Type
Experimental
Arm Description
We used the device (heart monitor) in the patients with myocardial infarction.
Arm Title
No Heart Monitor
Arm Type
Active Comparator
Arm Description
No heart monitor device in the patients with myocardial infarction (control).
Intervention Type
Device
Intervention Name(s)
Heart monitor
Other Intervention Name(s)
Heart monitor device
Intervention Description
Use of heart monitor device in the patients after acute myocardium infarct.
Intervention Type
Device
Intervention Name(s)
No heart monitor
Other Intervention Name(s)
No heart monitor device
Intervention Description
Standard monitoring by nurses.
Primary Outcome Measure Information:
Title
Heart rhythm monitoring
Description
Evaluating the effectiveness of a heart monitoring device in the prevention and detection of events in patients after acute myocardial infarction
Time Frame
One year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients over 18 years
patients post-acute myocardial infarctium
Exclusion Criteria:
patients with neurological disease
patients with congenital heart disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
silvia goldmeier, doctor
Phone
5132354127
Email
sgoldmeier@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
manoela vargas, student
Phone
5132354127
Email
vargas.manoela@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
silvia goldmeier
Organizational Affiliation
Instituto de Cardiologia do Rio Grande do Sul
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
Heart Monitoring Device After Acute Myocardium Infarction
We'll reach out to this number within 24 hrs